EKSO Q2 2022 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$29M

Q2 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$3M+56.7% YoY

Gross Profit

$2M47.4% margin

Operating Income

-$3M-93.2% margin

Net Income

-$3M-85.9% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

+35.0%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$621,000

Balance Sheet

Total Assets

$41M

Total Liabilities

$9M

Stockholders' Equity

$32M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+56.7%
Gross Profit	$2M	$1M	+27.0%
Operating Income	-$3M	-$3M	+3.6%
Net Income	-$3M	-$1M	-133.9%

Revenue Segments

EksoHealth

$3M93%

EksoWorks

$237,0007%

Geographic Segments

Americas

$2M33%

UNITED STATES

$2M31%

EMEA

$786,00012%

Asia Pacific

$488,0007%

APAC, Other

$330,0005%

EMEA, Other

$267,0004%

JAPAN

$205,0003%

GERMANY

$126,0002%

Americas, Other

$121,0002%